Literature DB >> 8453812

Systemic lupus erythematosus: neuropsychiatric signs and symptoms related to cerebral MRI findings.

K A Baum1, U Hopf, C Nehrig, M Stöver, W Schörner.   

Abstract

A 76.2% prevalence of abnormalities was found in the cerebral MR scans of 21 patients with systemic lupus erythematosus (SLE). These patients were enrolled in the study consecutively as they presented at an immunological out-patient unit. They were not selected on the basis of neuro/psychiatric findings. Circumscribed non-periventricular brain lesions were found in 12 patients (57.1%), mainly in the frontal white or gray matter. Periventricular lesions directly adjacent to the ventricles were detected in 10 patients (47.6%). Eleven patients (52.4%) showed signs of cerebral atrophy. MRI detected more lesions in patients with clinically focal CNS lupus than in patients with seizures or patients without clinically localized findings. Eleven patients had abnormal neuropsychiatric CNS findings; there was no clear correlation between neuropsychiatric signs and symptoms and brain abnormalities as shown by MRI. Seven patients had asymptomatic lesions. Cerebral MRI proved to be the method of choice for the non-clinical diagnosis of neuropsychiatric SLE.

Entities:  

Mesh:

Year:  1993        PMID: 8453812     DOI: 10.1016/0303-8467(93)90088-x

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  8 in total

1.  Neurobehavioural and psychiatric manifestations in a case of ANA-negative SLE with antiphospholipid antibodies.

Authors:  A Zoli; L Altomonte; A Galossi; A Taranto; L Mirone; M Magaró
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

2.  Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease.

Authors:  Boris Sakic; David L Kirkham; David A Ballok; James Mwanjewe; Ian M Fearon; Joseph Macri; Guanhua Yu; Michelle M Sidor; Judah A Denburg; Henry Szechtman; Jonathan Lau; Alexander K Ball; Laurie C Doering
Journal:  J Neuroimmunol       Date:  2005-09-29       Impact factor: 3.478

3.  Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice.

Authors:  Michelle M Sidor; Boris Sakic; Paul M Malinowski; David A Ballok; Curtis J Oleschuk; Joseph Macri
Journal:  J Neuroimmunol       Date:  2005-08       Impact factor: 3.478

4.  Cortical thickness and subcortical gray matter reductions in neuropsychiatric systemic lupus erythematosus.

Authors:  Rex E Jung; Judith M Segall; Rachael G Grazioplene; Clifford Qualls; Wilmer L Sibbitt; Carlos A Roldan
Journal:  PLoS One       Date:  2010-03-24       Impact factor: 3.240

Review 5.  Neuropsychological impairment in systemic lupus erythematosus: a comparison with multiple sclerosis.

Authors:  R H B Benedict; J L Shucard; R Zivadinov; D W Shucard
Journal:  Neuropsychol Rev       Date:  2008-06-03       Impact factor: 7.444

6.  Value of MRI of the brain in patients with systemic lupus erythematosus and neurologic disturbance.

Authors:  J E Jennings; P C Sundgren; J Attwood; J McCune; P Maly
Journal:  Neuroradiology       Date:  2003-11-27       Impact factor: 2.804

7.  Autoantibodies Affect Brain Density Reduction in Nonneuropsychiatric Systemic Lupus Erythematosus Patients.

Authors:  Jian Xu; Yuqi Cheng; Aiyun Lai; Zhaoping Lv; Robert A A Campbell; Hongjun Yu; Chunrong Luo; Baoci Shan; Lin Xu; Xiufeng Xu
Journal:  J Immunol Res       Date:  2015-05-18       Impact factor: 4.818

8.  Clinical Factors Associated with Brain Volume Reduction in Systemic Lupus Erythematosus Patients without Major Neuropsychiatric Manifestations.

Authors:  Shuang Liu; Yuqi Cheng; Yueyin Zhao; Hongjun Yu; Aiyun Lai; Zhaoping Lv; Xiufeng Xu; Chunrong Luo; Baoci Shan; Lin Xu; Jian Xu
Journal:  Front Psychiatry       Date:  2018-02-01       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.